Page last updated: 2024-08-25

terlipressin and Cholangiocellular Carcinoma

terlipressin has been researched along with Cholangiocellular Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Broelsch, CE; Frühauf, NR; Lang, H; Malagó, M; Saner, FH; Schäfers, RF1

Other Studies

1 other study(ies) available for terlipressin and Cholangiocellular Carcinoma

ArticleYear
Terlipressin plus hydroxyethyl starch infusion: an effective treatment for hepatorenal syndrome.
    European journal of gastroenterology & hepatology, 2003, Volume: 15, Issue:8

    Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Hydroxyethyl Starch Derivatives; Infusions, Intravenous; Lypressin; Male; Middle Aged; Plasma Substitutes; Postoperative Complications; Terlipressin; Vasoconstrictor Agents

2003